Skip to content
TrustList
Cambrian Biopharma logo
Venture capital firm

Cambrian Biopharma

Clinical-stage biotech developing medicines that target metabolic pathways that decline with age

Write a review
Visit WebsiteGet introducedWrite a Review
Own this listing? Claim it
Cambrian Biopharma cover

TrustList summary

Cambrian Biopharma, which trades as Cambrian Bio, is a clinical-stage drug development company. It works on therapies aimed at extending healthspan, meaning the years of life spent in good health. Its scientists focus on metabolic pathways that weaken with age, first as treatments and later as preventive medicines.

Products and services

  • Precision therapeutics: drug programmes aimed at pathways such as AMPK and mTOR.
  • Lead programme: ATX-304, described as the first AMPK network activator to enter clinical development, with early trial data in obesity and prediabetes.
  • Women's health: a programme area led by a director of women's health, linked to the company Oviva Therapeutics.
  • Shared support: scientific and operational teams that work across the pipeline programmes.

Who it serves

The company partners with scientists to develop new classes of medicines for patients with chronic metabolic disease and other age-related conditions.

Key facts

  • Stage: clinical.
  • Focus: metabolic disease and ageing biology.
  • Model: a group of pipeline programmes supported by a central team.

Summary written by TrustList from the business's own published information, Oct 2026.

Ask TrustList to introduce you to Cambrian Biopharma

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Cambrian Biopharma

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Cambrian Biopharma.

Cambrian Biopharma alternatives

Similar listings buyers compare against this one.

Compare side by side
Ignite Accelerator logo

Ignite Accelerator

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Zoovu logo

Zoovu

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

AIM Group logo

AIM Group

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Y Combinator logo

Y Combinator

Startup accelerator and early-stage investor running intensive batches for new technology founders

500 Global logo

500 Global

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Vodia Ventures logo

Vodia Ventures

Seed-stage investor in technology companies addressing social and environmental needs, from New York and Boston

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.